2113 Initial safety survey report from early post-marketing phase vigilance (EPPV) on TAS-102 for metastatic colorectal cancer (mCRC). (September 2015) - Muro, K.; Uetake, H.; Fujita, N.; Furuta, T.; Hara, N.; Katori, J.; Yoshino, T.